Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Sahm

Showing results (161-170 of 450) with videos related to

Pageof 45
Sort By:
Clinical Neurology and Neurosurgery|April 20, 2025
Mapping glioblastoma-induced neurological deficits: A brain atlasYeong Chul Yun, Sabine Wolf, Katharina Holz, et al.
Klinische Padiatrie|July 12, 2018
Molecular Diagnostics in Pediatric Brain Tumors: Impact on Diagnosis and Clinical Decision-Making - A Selected Case SeriesHeidi Bächli, Jonas Ecker, Cornelis van Tilburg, et al.
Neuro-Oncology Advances|July 30, 2025
Prognostic value of 1D, 2D, and volumetric tumor size increases in recurrent WHO grade 2 and 3 meningiomas: Radiological post-hoc analysis of the EORTC-BTG-1320 trialJulia Furtner, Luzia Berchtold, Emilie Le Rhun, et al.
Brain Pathology (Zurich, Switzerland)|April 2, 2024
A comprehensive histomolecular characterization of meningioangiomatosis: Further evidence for a precursor neoplastic lesionArnault Tauziède-Espariat, Julien Masliah-Planchon, Philipp Sievers, et al.
BMC Cancer|January 26, 2024
PerSurge (NOA-30) phase II trial of perampanel treatment around surgery in patients with progressive glioblastomaSophie Heuer, Ina Burghaus, Maria Gose, et al.
Neuro-Oncology Advances|August 3, 2022
AAMP is a binding partner of costimulatory human B7-H3Sara Ciprut, Anne Berberich, Maximilian Knoll, et al.
Acta Neuropathologica|September 7, 2018
Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastomaDamian Stichel, Azadeh Ebrahimi, David Reuss, et al.
Journal of Neuro-Oncology|November 24, 2023
Generation of patient-derived pediatric pilocytic astrocytoma in-vitro models using SV40 large T: evaluation of a modeling workflowFlorian Selt, Ahmed El Damaty, Martin U Schuhmann, et al.
Journal of Neuro-Oncology|February 9, 2024
Repeat surgery of recurrent glioma for molecularly informed treatment in the age of precision oncology: A risk-benefit analysisObada T Alhalabi, Philip Dao Trong, Manuel Kaes, et al.
Acta Neuropathologica|July 11, 2014
Whole exome sequencing reveals that the majority of schwannomatosis cases remain unexplained after excluding SMARCB1 and LZTR1 germline variantsSonja Hutter, Rosario M Piro, David E Reuss, et al.
Pageof 45

Showing results (161-170 of 450) with videos related to

Sort By:
Pageof 45
Clinical Neurology and Neurosurgery|April 20, 2025
Mapping glioblastoma-induced neurological deficits: A brain atlasYeong Chul Yun, Sabine Wolf, Katharina Holz, et al.
Klinische Padiatrie|July 12, 2018
Molecular Diagnostics in Pediatric Brain Tumors: Impact on Diagnosis and Clinical Decision-Making - A Selected Case SeriesHeidi Bächli, Jonas Ecker, Cornelis van Tilburg, et al.
Neuro-Oncology Advances|July 30, 2025
Prognostic value of 1D, 2D, and volumetric tumor size increases in recurrent WHO grade 2 and 3 meningiomas: Radiological post-hoc analysis of the EORTC-BTG-1320 trialJulia Furtner, Luzia Berchtold, Emilie Le Rhun, et al.
Brain Pathology (Zurich, Switzerland)|April 2, 2024
A comprehensive histomolecular characterization of meningioangiomatosis: Further evidence for a precursor neoplastic lesionArnault Tauziède-Espariat, Julien Masliah-Planchon, Philipp Sievers, et al.
BMC Cancer|January 26, 2024
PerSurge (NOA-30) phase II trial of perampanel treatment around surgery in patients with progressive glioblastomaSophie Heuer, Ina Burghaus, Maria Gose, et al.
Neuro-Oncology Advances|August 3, 2022
AAMP is a binding partner of costimulatory human B7-H3Sara Ciprut, Anne Berberich, Maximilian Knoll, et al.
Acta Neuropathologica|September 7, 2018
Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastomaDamian Stichel, Azadeh Ebrahimi, David Reuss, et al.
Journal of Neuro-Oncology|November 24, 2023
Generation of patient-derived pediatric pilocytic astrocytoma in-vitro models using SV40 large T: evaluation of a modeling workflowFlorian Selt, Ahmed El Damaty, Martin U Schuhmann, et al.
Journal of Neuro-Oncology|February 9, 2024
Repeat surgery of recurrent glioma for molecularly informed treatment in the age of precision oncology: A risk-benefit analysisObada T Alhalabi, Philip Dao Trong, Manuel Kaes, et al.
Acta Neuropathologica|July 11, 2014
Whole exome sequencing reveals that the majority of schwannomatosis cases remain unexplained after excluding SMARCB1 and LZTR1 germline variantsSonja Hutter, Rosario M Piro, David E Reuss, et al.
Pageof 45